Independent clinicians. Modern care.
Sinad Labs is building a different kind of telehealth company. We don't employ doctors. We don't push prescriptions. We connect patients with independent nurse practitioners and give those clinicians the tools, demand, and back-office support to practice the way they actually want to.
Our model
Sinad Labs is a management services organization (MSO). The term is wonky — what it means in practice is that we handle the non-clinical side of running a modern practice (technology, marketing, scheduling, billing, compliance operations) so the clinicians can focus on care.
The clinicians who see Sinad Labs patients work through their own professional entities — independent businesses that own all clinical decisions, from diagnosis to prescribing to follow-up. Sinad Labs doesn't tell them what to prescribe. We can't, and we wouldn't.
Built differently from the D2C playbook
A lot of D2C telehealth companies have been built around a single drug, a single condition, or a single sales funnel. That model is great at growth and bad at care.
Clinician-owned medicine
No corporate-employed doctors. No prescription quotas. No company-owned scripts.
Continuity by default
Every visit comes with follow-up included. The clinician you see is the clinician you message next week.
Cash-pay transparency
No surprise bills. Insurance is a roadmap item, not a moat.
Honest scope
If a problem isn't right for telehealth, we tell you and route you elsewhere.
Who we are
Sinad Labs was founded by operators with backgrounds in primary care, payor operations, and consumer technology. Our clinical advisory board includes board-certified family-medicine and psychiatric clinicians who guide our intake protocols and quality program.
Our quality program
Every visit's clinical decision-making is auditable. We monitor for outliers in prescribing, completion, and follow-up. Our quality program is designed by clinicians and runs independently of our growth team — because it has to.
Get in touch
Press, partnerships, or general inquiries — we'd love to hear from you.